AU6322900A - Method for generating resistance against cgmmv in plants, genetic constructs for use in said method, and cgmmv-resistant plants obtained via said method - Google Patents

Method for generating resistance against cgmmv in plants, genetic constructs for use in said method, and cgmmv-resistant plants obtained via said method

Info

Publication number
AU6322900A
AU6322900A AU63229/00A AU6322900A AU6322900A AU 6322900 A AU6322900 A AU 6322900A AU 63229/00 A AU63229/00 A AU 63229/00A AU 6322900 A AU6322900 A AU 6322900A AU 6322900 A AU6322900 A AU 6322900A
Authority
AU
Australia
Prior art keywords
cgmmv
plants
resistance against
obtained via
genetic constructs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63229/00A
Inventor
Michiel Theodoor Jan De Both
Bernarda Gerharda Johanna Fierens-Onstenk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Keygene NV
Original Assignee
Keygene NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keygene NV filed Critical Keygene NV
Publication of AU6322900A publication Critical patent/AU6322900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU63229/00A 1999-08-02 2000-07-27 Method for generating resistance against cgmmv in plants, genetic constructs for use in said method, and cgmmv-resistant plants obtained via said method Abandoned AU6322900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202540 1999-08-02
EP99202540 1999-08-02
PCT/NL2000/000534 WO2001009300A2 (en) 1999-08-02 2000-07-27 Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants

Publications (1)

Publication Number Publication Date
AU6322900A true AU6322900A (en) 2001-02-19

Family

ID=8240518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63229/00A Abandoned AU6322900A (en) 1999-08-02 2000-07-27 Method for generating resistance against cgmmv in plants, genetic constructs for use in said method, and cgmmv-resistant plants obtained via said method

Country Status (4)

Country Link
EP (1) EP1198572A2 (en)
AU (1) AU6322900A (en)
IL (1) IL147920A0 (en)
WO (1) WO2001009300A2 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002230284A1 (en) 2001-02-08 2002-08-19 Keygene N.V. Methods for generating resistance against cgmmv in plants
US8393001B1 (en) 2002-07-26 2013-03-05 Mcafee, Inc. Secure signature server system and associated method
DK1615646T4 (en) 2003-04-08 2022-10-10 Progenics Pharm Inc PHARMACEUTICAL FORMULATIONS CONTAINING METHYLNALTREXONE
ZA200607843B (en) * 2004-02-23 2008-06-25 Israel State Engrafted plants resistant to viral diseases and methods of producing same
AU2005325801A1 (en) 2005-01-31 2006-08-03 Ablynx N.V. Method for generating variable domain sequences of heavy chain antibodies
SG184709A1 (en) 2005-05-18 2012-10-30 Ablynx Nv Improved nanobodies™ against tumor necrosis factor-alpha
CA2960105A1 (en) 2005-05-20 2006-11-23 Ablynx Nv Single domain vhh antibodies against von willebrand factor
WO2008074840A2 (en) 2006-12-19 2008-06-26 Ablynx N.V. Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
WO2008074839A2 (en) 2006-12-19 2008-06-26 Ablynx N.V. Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
JP5266489B2 (en) * 2007-03-14 2013-08-21 国立大学法人愛媛大学 Gene silencing suppression technology
CA2865389A1 (en) 2007-03-29 2008-10-09 Progenics Pharmaceuticals, Inc. Crystal forms and uses thereof
AU2008328785A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Method for obtaining polypeptide constructs comprising two or more single domain antibodies
EP2240598B1 (en) 2008-01-10 2013-03-13 Enza Zaden Beheer B.V. Marker genetically linked to tobamovirus resistance in cucumber and the use thereof
AU2008349873B2 (en) 2008-02-06 2014-02-13 Progenics Pharmaceuticals, Inc. Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
GB2470328A (en) 2008-03-05 2010-11-17 Ablynx Nv Novel antigen binding dimer complexes, methods of making and uses thereof
EP2947097A1 (en) 2008-04-07 2015-11-25 Ablynx N.V. Amino acid sequences directed against the Notch pathways and uses thereof
AU2009237662A1 (en) 2008-04-17 2009-10-22 Ablynx N.V. Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
WO2010100135A1 (en) 2009-03-05 2010-09-10 Ablynx N.V. Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof
WO2010115998A2 (en) 2009-04-10 2010-10-14 Ablynx Nv Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
CA2764398A1 (en) 2009-06-05 2010-12-09 Erik Depla Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
WO2011040978A2 (en) 2009-10-02 2011-04-07 Ludwig Institute For Cancer Research Ltd. Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof
WO2011064382A1 (en) 2009-11-30 2011-06-03 Ablynx N.V. Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
EP2531523A1 (en) 2010-02-05 2012-12-12 Ablynx N.V. Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
KR101650995B1 (en) 2010-11-08 2016-08-25 노파르티스 아게 Cxcr2 binding polypeptides
WO2012175740A1 (en) 2011-06-23 2012-12-27 Ablynx Nv Immunoglobulin single variable domains directed against ige
US9328174B2 (en) 2012-05-09 2016-05-03 Novartis Ag Chemokine receptor binding polypeptides
WO2014087010A1 (en) 2012-12-07 2014-06-12 Ablynx N.V. IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
NL1040254C2 (en) 2013-05-17 2014-11-24 Ablynx Nv Stable formulations of immunoglobulin single variable domains and uses thereof.
NL2013007B1 (en) 2014-06-16 2016-07-05 Ablynx Nv Methods of treating TTP with immunoglobulin single variable domains and uses thereof.
NL2013661B1 (en) 2014-10-21 2016-10-05 Ablynx Nv KV1.3 Binding immunoglobulins.
JP6743051B2 (en) 2015-01-27 2020-08-19 ラヴァ・セラピューティクス・ベー・フェー Single domain antibody targeting CD1D
BR112018010802A2 (en) 2015-11-27 2018-11-27 Ablynx Nv cd40l inhibiting polypeptides
WO2018050833A1 (en) 2016-09-15 2018-03-22 Ablynx Nv Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
US11840569B2 (en) 2016-11-16 2023-12-12 Ablynx N.V. T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
US11603401B2 (en) 2017-06-02 2023-03-14 Ablynx N.V. Aggrecan binding immunoglobulins
MX2019014448A (en) 2017-06-02 2020-02-10 Merck Patent Gmbh Mmp13 binding immunoglobulins.
US11261260B2 (en) 2017-06-02 2022-03-01 Merck Patent Gmbh ADAMTS binding immunoglobulins
MX2019014397A (en) 2017-06-02 2020-02-10 Merck Patent Gmbh Polypeptides binding adamts5, mmp13 and aggrecan.
CN107860774B (en) * 2017-11-10 2020-01-07 青岛市农业科学研究院 Screening method of sensitive genotype of agrobacterium tumefaciens of cucumber
WO2019154867A1 (en) 2018-02-06 2019-08-15 Ablynx Nv Methods of treating initial episode of ttp with immunoglobulin single variable domains
EP3935084A1 (en) 2019-03-08 2022-01-12 LinXis B.V. Internalizing binding molecules targeting receptors involved in cell proliferation or cell differentiation
WO2020245663A1 (en) 2019-06-01 2020-12-10 Institut Pasteur Nanobody-based ns1 assay for the specific diagnosis of acute zika virus infection
EP4214235A1 (en) 2020-09-16 2023-07-26 LinXis B.V. Internalizing binding molecules
EP4019548A1 (en) 2020-12-23 2022-06-29 Vrije Universiteit Brussel Anti lag3 vhhs and their use
CN112920262B (en) * 2021-02-03 2022-09-16 浙江省农业科学院 Protein ClALKBH2B capable of inhibiting CGMMV accumulation, gene, expression vector, transformant and method thereof
CN115433733A (en) 2021-06-04 2022-12-06 生物岛实验室 Cyclic RNA (ribonucleic acid) Circ-ACE2 translated polypeptide and application thereof
AU2022372894A1 (en) 2021-10-20 2024-04-18 Takeda Pharmaceutical Company Limited Compositions targeting bcma and methods of use thereof
CN114107371B (en) * 2021-12-06 2024-03-29 中国农业科学院郑州果树研究所 Cucumber green mottle mosaic virus gene mediated transgenic tobacco method
CN116837004A (en) * 2021-12-06 2023-10-03 中国农业科学院郑州果树研究所 Chimeric structure IMC and application thereof in cucumber green mottle mosaic virus resistant tobacco cultivation
WO2024023271A1 (en) 2022-07-27 2024-02-01 Ablynx Nv Polypeptides binding to a specific epitope of the neonatal fc receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2078134A1 (en) * 1990-03-12 1991-09-13 Milton Zaitlin Transformation of plants with non-structural plant virus gene sequences
GB9208545D0 (en) * 1992-04-21 1992-06-03 Gatsby Charitable Foundation T Virus resistant plants

Also Published As

Publication number Publication date
EP1198572A2 (en) 2002-04-24
IL147920A0 (en) 2002-08-14
WO2001009300A3 (en) 2001-08-23
WO2001009300A2 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
AU6322900A (en) Method for generating resistance against cgmmv in plants, genetic constructs for use in said method, and cgmmv-resistant plants obtained via said method
AU2001268395A1 (en) Hardfacing alloy, methods, and products
AU2002230642A1 (en) Proton generating catheters and methods for their use
AU2003251858A1 (en) Microbubble compositions, and methods for preparing and using same
MXPA02002192A (en) International trading system and method.
AU3920700A (en) System, device and method for estimating evapo-transpiration in plants
EP1577384A4 (en) Plant with reduced protein content in seed, method of constructing the same and method of using the same
AU4217299A (en) Pth1r and pth3r receptors, methods and uses thereof
AU6576500A (en) Feline calicivirus genes and vaccines, in particular recombined vaccines
AU2001268986A1 (en) Method for inducing viral resistance in plants
AU2001264935A1 (en) Method for introducing and expressing genes in animal cells, and bacterial blebsfor use in same
AU2001271890A1 (en) Methods for regulating beta-oxidation in plants
AU5843499A (en) Method for improving immunity in plants and animals
EP1544701A4 (en) Abnormality-diagnosing system in plant control system, and abnormality-diagnosing method
AU2000276023A1 (en) Novel formulation for counteracting an ethylene response in plants, preparation process thereof, and method using the same
AU3617401A (en) Tying clips, pliers and method for the use thereof
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU4771600A (en) Cells, culture methods and their uses
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2001248456A1 (en) Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides
GB2349332B (en) Tuft, upholstery and method
AU2001280252A1 (en) Method for preparing organoaluminum silicates and their use in balanced animal feed
AU1602301A (en) Method for enhancing resistance in plants
AU7560200A (en) Fat originating in cupuassu seed, process for producing the same and use thereof
AU1534895A (en) Weed-suppressing agent, method for preparing it and its use in weed control

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase